Back close

Effect of Volatile Compounds on Pulmonary Pathogens

Start Date: Sunday, Jan 01,2012

End Date: Wednesday, May 30,2012

School: School of Biotechnology

Thematic Area: Biotech

Project Incharge:Ajith Madhavan
Co-Project Incharge:Amrita Vijay, Amrutha V, Anju Venugopal, Lavanya Ramachandran M, Malini V, Saranya K R
Effect of Volatile Compounds on Pulmonary Pathogens

Pulmonary diseases are very common. The main causative agents of these diseases are Klebsiella pneumonia, Staphylococcus aureus, Pseudomonas aeruginosa, haemophilus influenza etc. Medication is the most important treatment of most diseases of pulmonology. The essential oils produced by many plants have been traditionally used for curing respiratory tract infections and are used as ethical medicines for cold. These oils have antimicrobial activity. This project aimed to the inhibitory action of certain volatile compounds against tha organisms causing pulmonary diseases. It is started with a noval etraction procedure of volatile compounds from the winter green oil and an Ayurvedic preparation of turmeric and ghee. Biological assay, turbidometric method and well diffusion method was done to check the antimicrobial activity of volatile compounds against selected pathogens. Biological assay and turbidometric method was based on the bacterial concentration(OD).

Related Projects

Expression, Purification And Refolding Of Recombinant Amidase In Escherichia Coli
Expression, Purification And Refolding Of Recombinant Amidase In Escherichia Coli
Isolation,Partial Purification and Characterisation of Bacteriocins from Fermented Foods
Isolation,Partial Purification and Characterisation of Bacteriocins from Fermented Foods
Screening for Quorum Sensing Inhibitors from Edible Leaves and Oils
Screening for Quorum Sensing Inhibitors from Edible Leaves and Oils
Isolation and identification of endophytes from marine algae
Isolation and identification of endophytes from marine algae
Development of Host-directed Therapies for Drug Resistant Klebsiella Pneumonia Infections
Development of Host-directed Therapies for Drug Resistant Klebsiella Pneumonia Infections
Admissions Apply Now